ATC level 4
J05ABDirect acting antiviral, subgroup J05AB
- Molecules
- 9
- Subgroups
- 9
ATC J05AB (Direct acting antiviral, subgroup J05AB) is a level 4 group in the anatomical therapeutic chemical classification. The catalogue lists 9 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under J05AB.
- AcyclovirOrphanHerpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor14 presentations2 brandsD06BB03
- CidofovirCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor1 presentationJ05AB12
- FamciclovirHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor3 presentationsJ05AB09
- GanciclovirOrphanCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor3 presentations1 brandJ05AB06
- PenciclovirHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor2 presentations1 brandD06BB06
- RemdesivirSARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor1 presentation2 brandsJ05AB16
- RibavirinOrphanNucleoside Analog3 presentationsJ05AB04
- ValacyclovirHerpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor4 presentations1 brandJ05AB11
- ValganciclovirCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor4 presentations1 brandJ05AB14
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.